Bibliografia: Ginecologia di segnale: Sindrome dell’ovaio policistico

Articolo L’altra Medicina N. 96 – 06/2020

Riferimenti bibliografici

1. Tissue insulin sensitivity and body weight in polycystic ovary syndrome. PJ Marsden, AP Murdoch, R Taylor – Clinical endocrinology, 2001
2. Polycystic ovarian syndrome (PCOS) and insulin resistance. KH Park, et al. International Journal, 2001 
3. Gut microbiota-bile acid-interleukin-22 axis orchestrates polycystic ovary syndrome. Qi X et al. Nat Med. Epub 2019 Jul 22.
4. Polycystic ovary syndrome in adolescents: pathophysiology and treatment implications. Pelusi C, Pasquali R. Treat Endocrinol. 2003;
5. Changes in luteinizing hormone and insulin secretion in polycystic ovarian syndrome. Fulghesu AM. Hum Reprod. 1999 Mar;
6. Comment on “Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome”. Ciampelli M, Fulghesu AM, Lanzone A. J Clin Endocrinol Metab. 1999 Aug;
7. Are there really any predictive factors for a successful weight loss after bariatric surgery? Cadena-Obando, Ramírez-Rentería C, Ferreira-Hermosillo A, Albarrán-Sanchez A, Sosa-Eroza E, Molina-Ayala M, Espinosa-Cárdenas E. BMC Endocr Disord. 2020 Feb 5;20(1):20. doi: 10.1186/s12902-020-0499-4.
8. Disordered eating after bariatric surgery: clinical aspects, impact on outcomes, and intervention strategies. Conceição EM, Goldschmidt A. Curr Opin Psychiatry. 2019 Nov;32(6):504-509.
9. Cognitive behavioral therapy and predictors of weight loss in bariatric surgery patients. Paul L, van der Heiden C, Hoek HW. Curr Opin Psychiatry. 2017 Nov; 30(6):474-479
10. Development and validation of a new questionnaire measuring eating disordered behaviours post bariatric surgery. Weineland S, Alfonsson S, Dahl J, Ghaderi A.Clin Obes. 2012 Oct; 2(5-6):160-7. Epub 2013 Jan 14
11. Multi-sensor ecological momentary assessment of behavioral and psychosocial predictors of weight loss following bariatric surgery: study protocol for a multicenter prospective longitudinal evaluation.

Goldstein SP, Thomas JG, Vithiananthan S, Blackburn GA, Jones DB, Webster J, Jones R, Evans EW, Dushay J, Moon J, et al.BMC Obes. 2018; 5:27. Epub 2018 Nov 5 J

12. Perioperative and Postoperative Effects of Preoperative Low-Calorie Restrictive Diets on Patients Undergoing Laparoscopic Sleeve Gastrectomy.Ekici U, Ferhatoglu MF. Gastrointest Surg. 2020 Feb;24(2):313-319. doi: 10.1007/s11605-019-04157-5. Epub 2019 Feb 20.
13. Long-Term (over 13 Years) Follow-Up of Vertical Band Gastroplasty. Froylich D, Abramovich TS, Fuchs S, Zippel D, Hazzan D. Obes Surg. 2020 Feb 11.
14. Surgery for weight loss in adults.Colquitt JL 1 , Pickett K , Loveman E , Frampton GK . Cochrane Database Syst Rev. 2014 ago 8; (8): CD003641. doi: 10.1002 / 14651858.CD003641.pub4.
15. The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation. Picot J1, Jones J, Colquitt JL, Gospodarevskaya E, Loveman E, Baxter L, Clegg AJ. Health Technol Assess. 2009 Sep;13(41):1-190, 215-357, iii-iv. doi: 10.3310/hta13410
16. Bariatric surgery: an evidence-based analysis. Medical Advisory Secretariat.Ont Health Technol Assess Ser. 2005;5(1):1-148. Epub 2005 Jan 1
17. Glycemic control in diabetes is restored by therapeutic manipulation of cytokines that regulate beta cell stress, Nat Med 2014. Hasnain Z
18. Interleukin-22 alleviates metabolic disorders and restores mucosal immunity in diabetes, Wang X, Nat 2014
19. Androgeno-estrogeni nelle donne con metabolismo corpo superiore Versus inferiore del corpo obesità. MA Kirschner et al. The Journal of Clinical Endocrinology & Metabolism , Volume 70, Numero 2, 1 febbraio 1990
20. Polycystic ovary syndrome in adolescents: pathophysiology and treatment implications. Pelusi C, Pasquali R. Treat Endocrinol. 2003;
21. Changes in luteinizing hormone and insulin secretion in polycystic ovarian syndrome. Fulghesu AM. Hum Reprod. 1999 Mar;
22. Comment on “Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome”. Ciampelli M, Fulghesu AM, Lanzone A. J Clin Endocrinol Metab. 1999 Aug;
23. Effects of weight loss on the hormonal profile in obese, infertile women. Hollmann M. Hum Reprod 1996 Sep
24. The contribution of physical activity and sedentary behaviours to the growth and development of children and adolescents: implications for overweight and obesity. Hills AP et al. 2007. Sports Med.
25. Exercise therapy in polycystic ovary syndrome: a systematic review. Human Reproduction Update, Volume 17, Issue 2, March-April 2010. Cheryce L. Harrison, Catherine B. Lombard, Lisa J. Moran, Helena J. Teede
26. Physical activity and obesity in children. Hills AP et al 2011. Br J Sports Med.
27. The importance of physical activity in the prevention of overweight and obesity in childhood: a review and an opinion. Steinbeck KS, 2001. Obes Rev.May
28. How physical activity can work? Fogelholm M, 2008. Int J Pediatr Obes.
29. Treatment strategies for obesity. J. P. H. Wilding. First published: 19 February 2007. Obesity Reviews
30. Lifestyle changes in women with polycystic ovary syndrome.Moran LJ et al.2011 Feb. Cochrane Database Syst Rev.
31. Dietary composition in the treatment of polycystic ovary syndrome: a systematic review to inform evidence-based guidelines. Lisa J. Moran, et al. Human Reproduction Update, Volume 19, Issue 5, September/October 2013
32. Glycemia and insulinemia in healthy subjects after lactose-equivalent meals of milk and other food proteins: the role of plasma amino acids and incretins. Nilsson, Am J Clini Nutr, 2004
33. Metabolic effects of amino acid mixtures and whey protein in healthy subjects: studies using glucose-equivalent drinks. Mikael Nilsson, Am J of Clinical Nutrition, 2007.
34. Effects of caloric intake timing on insulin resistance and hyperandrogenism in lean women with polycystic ovary syndrome. Jakubowicz D. Clin Sci (London), 2013 Nov.
35. Reflections on inositol(s) for PCOS therapy: steps toward success. Gynecol Endocrinol 2015 Jul; Nestler JE, Unfer V
36. Ovulatory and metabolic effects of D-chiro-inositol in the polycystic ovary syndrome, in N Engl J Med, 1999. Nestler J E, Jakubowicz D J, Reamer P, Gunn R D, Allan G,
37. Effects of d-chiro-inositol in lean women with the polycystic ovary syndrome, in Endocr Pract, 2002. Iuorno M J, Jakubowicz D J, Baillargeon J P, Dillon P, Gunn R D, Allan G, Nestler J E